Cancer News - Topix
Shares of biotechnology company Endocyte Inc. rose in afternoon trading Friday, after the company slashed pricing expectations for its initial public offering.
Sent with Reeder
Sent from my iPad
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment